HOME >> MEDICINE >> NEWS
ACPM recommends research priorities for child and adolescent immunizations

Washington, D.C. - The American College of Preventive Medicine (ACPM) recommended today research priorities that aim to encourage the development of new vaccines and increase immunization rates. Developing new combinations of vaccines and needleless vaccine delivery systems are among the key recommendations. If implemented on a population-wide basis, such improvements would increase immunization rates by reducing the inefficiency of multiple injections and by minimizing the emotional and physical trauma in children.

According to Dr. Yemisi Adetunji, the lead author of ACPM's recommendations, "Despite the incontrovertible evidence that vaccines are an efficient and cost-effective means of reducing morbidity and mortality, immunization delivery remains suboptimal among young children.

Immunization rates in areas of poverty and many metropolitan areas with large populations of low-income residents remain below national levels. We can do better to protect our children's health."

Other research priorities from ACPM address issues of vaccine supply, the effectiveness of recommended interventions, and better funding for immunization programs. In addition to its research priorities, ACPM recommends that all children and adolescents without established contraindications receive immunization against 11 diseases: diphtheria, tetanus, pertussis, measles, mumps, rubella, polio, H. influenza b (Hib), hepatitis B, varicella (i.e., chickenpox), and S. pneumoniae. The ACPM recommendations are in accordance with the schedule of childhood immunizations recommended by the Advisory Committee on Immunization Practices.

ACPM's recommendations on childhood immunizations appear in the August 2003 issue of the American Journal of Preventive Medicine. The statement can be viewed at http://www.acpm.org .


'"/>

Contact: Jennifer K. Bretsch
jkb@acpm.org
202-466-2044
American College of Preventive Medicine
13-Aug-2003


Page: 1

Related medicine news :

1. Mayo Clinic recommends broadening treatment to battle recurrence of endometrial cancer
2. IDSA recommends ways to strengthen HHSs pandemic influenza plan
3. ACPM recommends reproductive health care benefits for adolescents
4. Study recommends 50% reduction in CT radiation dose based on patient size and weight
5. Foot and mouth report recommends major changes to the lamb supply chain
6. FDA advisory committee recommends approval of novantrone for treatment of worsening multiple sclerosis
7. Public morally obliged to take part in scientific research, says leading ethicist
8. U of M researcher says Viagra may cause permanent vision loss in some men
9. Indiana University researchers closer to helping hearing-impaired using stem cells
10. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
11. RIT takes eye-tracking research to next level

Post Your Comments:
(Date:3/6/2015)... The Public Health Accreditation Board ... status to seven more health departments. This week’s decisions ... people can now be assured that their health departments ... of their communities. , Public health departments play a ... people and communities. Across the nation, health departments provide ...
(Date:3/5/2015)... global digital PCR (dPCR) and qPCR market is expected to reach ... 2019. , The global digital PCR (dPCR) and qPCR market is ... 2019. Although the mature markets such as the U.S., Germany, France ... qPCR market the Asia-Pacific region is expected to grow at the ... the digital PCR (dPCR) and qPCR market is driven by factors ...
(Date:3/5/2015)... 05, 2015 A Bakersfield, Calif. state court ... trial awarding the plaintiff Coleen M. Perry a total ... of a TVT-Abbrevo pelvic mesh sling device, manufactured by Ethicon, ... Cartmell , a partner at Wagstaff & Cartmell ... the plaintiff, along with Rich Freese and Tim Goss of ...
(Date:3/5/2015)... New York (PRWEB) March 05, 2015 ... men who allegedly suffered heart attacks, strokes and other ... low testosterone therapies continue to move forward in the ... Northern District of Illinois. According to a Case Management ... forth procedures for the use of master pleadings in ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 ... this March with extra savings on their ... important of health and nutrition, HomeCEUConnection.com is ... using the promo code, NUTRITION2015 . ... Professionals , HomeCEUConnection.com provides high-quality continuing ...
Breaking Medicine News(10 mins):Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2
(Date:3/5/2015)...  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... chronic pain, today announced the appointment of several ... panel of experts will provide support for planning ... the company pipeline of novel investigational therapies to ... range of areas including opioid receptors, addiction, psychiatry, ...
(Date:3/5/2015)... -- LUNGevity Foundation, the nation,s leading lung cancer ... approval of Bristol Myers Squibb,s new immunotherapy drug ... another critical new treatment option to fight lung ... own immune system to fight cancerous cells. Importantly, ... with squamous cell lung cancer, a population for ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... the "Japan Pharma Outlook 2015: Year to Watch ... Initiatives" report to their offering. ... from April -2014 (Annexure 1) is a ... - whether generic or innovator. The most of the ...
Breaking Medicine Technology:Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3
Cached News: